Cargando…
Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review
Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy-induced peripheral neuropathy (CIPN). The health consequences of CIPN remain worrying as it is associated with several comorbidities...
Autores principales: | Kerckhove, Nicolas, Collin, Aurore, Condé, Sakahlé, Chaleteix, Carine, Pezet, Denis, Balayssac, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323411/ https://www.ncbi.nlm.nih.gov/pubmed/28286483 http://dx.doi.org/10.3389/fphar.2017.00086 |
Ejemplares similares
-
Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study
por: Selvy, Marie, et al.
Publicado: (2021) -
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021) -
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2022) -
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup
por: Kerckhove, Nicolas, et al.
Publicado: (2019) -
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)